Radiolabeling of magnetic targeted carriers (MTC) with indium-111

This publication has 20 references indexed in Scilit:

• Cancer-Targeted Polymeric Drugs
  Current Cancer Drug Targets, 2002
• Tumor Vasculature Directed Drug Targeting: Applying New Technologies and Knowledge to the Development of Clinically Relevant Therapies
  Pharmaceutical Research, 2002
• Yttrium 90 ibritumomab tiuxetan radioimmunotherapy for relapsed or refractory low-grade non-Hodgkin's lymphoma
  Seminars in Oncology, 2002
• Randomised trial of SIR-Spheres® plus chemotherapy vs. chemotherapy alone for treating patients with liver metastases from primary large bowel cancer
  Annals of Oncology, 2001
• Delivery systems intended for in vivo gene therapy of cancer: targeting and replication competent viral vectors
  Critical Reviews in Oncology/Hematology, 2001
• Receptor Targeting for Tumor Localisation and Therapy with Radiopeptides
  Current Medicinal Chemistry, 2000
• Preparation, characterization, and performance of magnetic iron–carbon composite microparticles for chemotherapy
  Biomaterials, 2000
• Phase I/II 90 Y-Zevalin (yttrium-90 ibritumomab tiuxetan, IDEC-Y2B8) radioimmunotherapy dosimetry results in relapsed or refractory non-Hodgkin's lymphoma
  European Journal of Nuclear Medicine and Molecular Imaging, 2000
• Receptor-mediated and enzyme-dependent targeting of cytotoxic anticancer drugs
  Pharmacology & Therapeutics, 1999
• Future developments in the selectivity of anticancer agents: Drug delivery and molecular target strategies
  Cancer and Metastasis Reviews, 1998